Rituximab as a first-line preventive treatment in pediatric NMOSDs: Preliminary results in 5 children

OBJECTIVE: No established therapeutic protocol has been proposed to date for childhood-onset neuromyelitis optica (NMO) spectrum disorders (NMOSDs). We report the response of 5 NMO immunoglobulin (Ig)G–positive pediatric cases to a standardized B-cell–targeted first-line immunosuppressive protocol w...

Descripción completa

Detalles Bibliográficos
Autores principales: Longoni, Giulia, Banwell, Brenda, Filippi, Massimo, Yeh, E. Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268036/
https://www.ncbi.nlm.nih.gov/pubmed/25520954
http://dx.doi.org/10.1212/NXI.0000000000000046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268036/
https://www.ncbi.nlm.nih.gov/pubmed/25520954
http://dx.doi.org/10.1212/NXI.0000000000000046

Ejemplares similares